Liver X receptor modulators: a review of recently patented compounds (2009 - 2012). - Wikidata - awgldk - TriplyDB

Liver X receptor modulators: a review of recently patented compounds (2009 - 2012).

Liver X receptor modulators: a review of recently patented compounds (2009 - 2012).

http://www.wikidata.org/entity/Q38119248

about

Cyclodextrins as Emerging Therapeutic Tools in the Treatment of Cholesterol-Associated Vascular and Neurodegenerative Diseases Liver X receptors at the intersection of lipid metabolism and atherogenesis Xylobiose, an Alternative Sweetener, Ameliorates Diabetes-Related Metabolic Changes by Regulating Hepatic Lipogenesis and miR-122a/33a in db/db Mice Impaired clearance of apoptotic cells in chronic inflammatory diseases: therapeutic implications RNA sequencing-based analysis of gallbladder cancer reveals the importance of the liver X receptor and lipid metabolism in gallbladder cancer Sterol O-Acyltransferase 2-Driven Cholesterol Esterification Opposes Liver X Receptor-Stimulated Fecal Neutral Sterol Loss.Liver x receptor agonists for the treatment of coronary heart disease and other disorders.Perilipin 5 and Liver fatty acid binding protein function to restore quiescence in mouse hepatic stellate cells.The liver X receptor agonist AZ876 protects against pathological cardiac hypertrophy and fibrosis without lipogenic side effects.The Role of PPAR and Its Cross-Talk with CAR and LXR in Obesity and Atherosclerosis.

P2860

Q28071254-0CDEB645-4A02-4038-A89C-774C325D02D5 Q28082452-B1225BF5-5735-4B30-98BF-958890571BB0 Q28354289-7A549EA1-E4E7-4704-B40F-7D0708EFBB1C Q33984427-1B573C50-F08E-4155-8DF4-ACE699D32FFB Q37376541-0C0B6EF4-A464-4490-BF80-48D0A14FCF09 Q37573558-9448DCFF-ED10-4D1C-AE20-0DD736AC78C6 Q43007834-B07ABE53-B7D3-4358-B9B1-3B054E29851B Q47215914-CE43F5DC-2DBE-4B2A-B401-D89EA39A74B8 Q53615353-C77BFD94-FD4E-4443-852F-428AA7AA4201 Q54988933-60281CFA-E813-4E4F-8C55-533267A362D7

P2860

Liver X receptor modulators: a review of recently patented compounds (2009 - 2012).

http://www.wikidata.org/entity/Q38119248

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Liver X receptor modulators: a review of recently patented compounds (2009 - 2012).

@en

type

label

Liver X receptor modulators: a review of recently patented compounds (2009 - 2012).

@en

prefLabel

Liver X receptor modulators: a review of recently patented compounds (2009 - 2012).

@en

P1433

Q38119248-9B712A64-6B02-424F-AA89-5411B910EC7D

P1476

Q38119248-4C3628FE-B670-4D76-A467-3A1F52ECC1F9

P2093

Q38119248-586905F0-D767-4235-9DF5-B71DD56FB05F

Q38119248-881144D0-024A-4C25-BC78-4E3DB8DBEDFC

Q38119248-981F4EE8-E659-46AD-BD1F-11FF51A236BB

Q38119248-9D8B8D39-03DF-4DAD-859A-ABB5906D1D2C

P2860

Q38119248-0FA5A9DF-628F-4AC7-AA35-2B14EF001464

Q38119248-10746895-51EA-4C72-9A37-D01D7474E01D

Q38119248-135993F5-B014-4AF3-965B-634F029182A5

Q38119248-168CF135-C51B-45F1-BAEB-F8A05F36860A

Q38119248-17D194CD-43FB-465D-BFD8-926FE25735BE

Q38119248-19EE077F-3428-4D9D-9A76-E3CDA306621F

Q38119248-2374D560-CD08-43FA-AFC3-1F0FC586108E

Q38119248-25ED885F-CC74-4F44-89C7-88B63102577B

Q38119248-28308407-FB01-45DD-A373-538D24B6C9A2

Q38119248-2938D825-B62E-470A-A3B4-2336E71F95DA

P304

Q38119248-E63B5C95-7D2E-4F66-9573-3CAAE68F8748

P31

Q38119248-B21C513F-4092-4151-9444-CA63AE499BB3

P356

Q38119248-45DB2D69-ED50-4655-BED1-912031BCBF58

P407

Q38119248-F6B0AC60-4293-476E-B034-5999044C22F5

P433

Q38119248-8D0377D3-5BB4-453E-84BB-1458D42256E6

P478

Q38119248-C48C3431-D2F0-48C9-BD05-592F4C608629

P577

Q38119248-454410F4-D917-4955-B845-83054076D576

P698

Q38119248-DAC3307D-B610-4C2D-AE6A-019DD6FCD990

P921

Q38119248-F12D7755-1716-46BA-90D8-E70116775A79

P356

13543776.2013.814640

P1433

Expert Opinion on Therapeutic Patents

P1476

Liver X receptor modulators: a review of recently patented compounds (2009 - 2012).

@en

P2093

Bryan A Laffitte

http://www.w3.org/2001/XMLSchema#string

Jon Loren

http://www.w3.org/2001/XMLSchema#string

Valentina Molteni

http://www.w3.org/2001/XMLSchema#string

Zhihong Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency

Role of LXRs in control of lipogenesis

Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters

Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor

Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway

Synthetic LXR ligand inhibits the development of atherosclerosis in mice

LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes

Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta

Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses

Atherosclerosis

P304

1317-1335

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543776.2013.814640

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23826715

http://www.w3.org/2001/XMLSchema#string

P921